Contact:
dloynd@endurxpharm.com
EnduRx Pharmaceuticals Inc. 8340 N Thornydale Rd Suite 110-328, Tucson, AZ 85741 (855) 368-2878
EnduRx Pharmaceuticals is a wholly-owned subsidiary of OBDURO Biotechnologies
Development of a Novel Tumor-Targeting and Tumor-Penetrating Nanosystem for Breast Cancer Therapy
Sonke Svenson, PhD
Chief Scientific Officer
David Loynd
President & CEO
Steve Morris, MD
Chief Medical Officer
Funded by:
Department of Defense - Congressionally Directed Medical Research Programs
FY 19, Breast Cancer Research Program
Award W81XWH2010122 Amount $1,412,301.00
Principal Investigator: Stephan Morris